Cargando…
Gut-lung cross talk in COVID-19 pathology and fatality rate
Coronavirus disease 2019 (COVID-19) is the leading pandemic facing the world in 2019/2020; it is caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which necessitates clear understanding of the infectious agent. The virus manifests aggressive behavior with seve...
Autores principales: | El-Ansary, Afaf, Balto, Hanan, Al-Hadlaq, Solaiman M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988877/ http://dx.doi.org/10.1016/B978-0-323-90769-9.00037-2 |
Ejemplares similares
-
Gum-gut axis: The potential role of salivary biomarkers in the diagnosis and monitoring progress of inflammatory bowel diseases
por: Balto, Hanan, et al.
Publicado: (2023) -
Control of antibiotic resistance and superinfections as a strategy to manage COVID-19 deaths
por: El-Ansary, Afaf, et al.
Publicado: (2022) -
Biomarkers of non-communicable chronic disease: an update on contemporary methods
por: Al-hadlaq, Solaiman M., et al.
Publicado: (2022) -
Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications
por: Alenazy, Maha F., et al.
Publicado: (2022) -
Challenges in postgraduate research
por: Al-Hadlaq, Solaiman M.
Publicado: (2019)